Influence of BMI on outcomes of high-dose cytarabine and mitoxantrone induction therapy for AML

被引：0
|
作者：
Burhani, Mansoor [1 ]
Dave, Manish J. [1 ]
Venugopal, Parameswaran [1 ]
Larson, Melissa L. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7106
引用
收藏
页数：1
相关论文
共 50 条
  • [31] High-dose cytarabine produces high cure rate in some AML patients
    不详
    ONCOLOGY-NEW YORK, 1999, 13 (02): : 213 - 213
  • [32] Safety and feasibility of outpatient high-dose cytarabine (HIDAC) and intermediate-dose cytarabine (IDAC) for consolidation therapy in acute myeloid leukemia (AML).
    Li, Wenhui
    Simondsen, Katherine
    Lee, Jamie
    Elharake, Maher
    Kubal, Timothy Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine
    Raanani, P
    Shpilberg, O
    Gillis, S
    Avigdor, A
    Hardan, I
    Berkowicz, M
    Sofer, O
    Lossos, I
    Chetrit, A
    Ben-Yehuda, D
    Bell-Bassat, I
    LEUKEMIA RESEARCH, 1999, 23 (08) : 695 - 700
  • [34] A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
    Wang, Amy Y.
    Weiner, Howard
    Green, Margaret
    Chang, Hua
    Fulton, Noreen
    Larson, Richard A.
    Odenike, Olatoyosi
    Artz, Andrew S.
    Bishop, Michael R.
    Godley, Lucy A.
    Thirman, Michael J.
    Kosuri, Satyajit
    Churpek, Jane E.
    Curran, Emily
    Pettit, Kristen
    Stock, Wendy
    Liu, Hongtao
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11 : 4
  • [35] A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
    Amy Y. Wang
    Howard Weiner
    Margaret Green
    Hua Chang
    Noreen Fulton
    Richard A. Larson
    Olatoyosi Odenike
    Andrew S. Artz
    Michael R. Bishop
    Lucy A. Godley
    Michael J. Thirman
    Satyajit Kosuri
    Jane E. Churpek
    Emily Curran
    Kristen Pettit
    Wendy Stock
    Hongtao Liu
    Journal of Hematology & Oncology, 11
  • [36] Results of high-dose cytarabine consolidation and interferon alpha maintenance therapy in acute myeloid leukemia (AML)
    Saikia, TK
    Advani, SH
    Gopal, R
    Nair, CN
    Sawant, VS
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 226 - 226
  • [37] A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL.
    Weiss, MA
    Heffner, L
    Lamanna, N
    Kalaycio, M
    Schiller, G
    Coutre, S
    Maslak, P
    Jurcic, J
    Panageas, K
    Scheinberg, DA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 564S - 564S
  • [38] Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy
    Huetter-Kroenke, Marie-Luise
    Benner, Axel
    Doehner, Konstanze
    Krauter, Juergen
    Weber, Daniela
    Moessner, Margit
    Koehne, Claus-Henning
    Horst, Heinz A.
    Schmidt-Wolf, Ingo G. H.
    Rummel, Mathias
    Goetze, Katharina
    Koller, Elisabeth
    Petzer, Andreas L.
    Salwender, Hans
    Fiedler, Walter
    Kirchen, Heinz
    Haase, Detlef
    Kremers, Stephan
    Theobald, Matthias
    Matzdorff, Axel C.
    Ganser, Arnold
    Doehner, Hartmut
    Schlenk, Richard F.
    HAEMATOLOGICA, 2016, 101 (07) : 839 - 845
  • [39] INDUCTION THERAPY WITH HIGH-DOSE CYTARABINE AND ANTHRACYCLINES IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
    Gil, Perez Angela
    Vazquez, Ramo Alejandro
    De Rojas, de Pablo Teresa
    Torralba, Gomez de Suso Miguel
    Nuevo, Lopez Irene
    Subira, Perez Dolores
    Merchan, Munoz Beatriz
    Perez, Ortega Alba
    De Miguel, Llorente Dunia
    HAEMATOLOGICA, 2020, 105 : 384 - 385
  • [40] Treatment of Therapy-Related Myeloid Neoplasms with High-Dose Cytarabine/Mitoxantrone Followed by Hematopoietic Cell Transplantation (HCT).
    Godley, Lucy A.
    Njiaju, Uchenna O.
    Green, Margaret
    Weiner, Howard
    Lin, Shang
    Odenike, Olatoyosi
    Rich, Elizabeth Shima
    Artz, Andrew
    van Besien, Koen
    Daugherty, Christopher
    Zhang, Yanming
    Le Beau, Michelle M.
    Stock, Wendy
    Larson, Richard A.
    BLOOD, 2009, 114 (22) : 426 - 426
12345